Literature DB >> 10892708

Pathogenesis of cutaneous lymphomas.

R Dummer1, J Willers, J Kamarashev, M Urosevic, U Döbbeling, G Burg.   

Abstract

Cutaneous lymphomas are a heterogeneous group of lymphoproliferative disorders derived from T cells, B cells and, in rare cases, natural killer cells. The precise mechanisms of the lymphomagenesis are still obscure. However, there are various factors involved. These factors include environmental, especially infectious factors, translocations, mutations and genetic instability. The special microenvironment in the skin is responsible for the peculiar behavior of these neoplasms by providing various key factors, such as adhesion molecules and cytokines. Newly identified molecular disturbances in cutaneous lymphomas might be targeted by specific molecular or immunologic interventions in the future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10892708     DOI: 10.1016/s1085-5629(00)80003-6

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  3 in total

Review 1.  Clinical and biological significance of HLA-G expression in ovarian cancer.

Authors:  Jim Jinn-Chyuan Sheu; Ie-Ming Shih
Journal:  Semin Cancer Biol       Date:  2007-07-03       Impact factor: 15.707

2.  TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.

Authors:  Brigitte Dreno; Mirjana Urosevic-Maiwald; Youn Kim; Joan Guitart; Madeleine Duvic; Olivier Dereure; Amir Khammari; Anne-Chantal Knol; Anna Derbij; Monika Lusky; Isabelle Didillon; Anne-Marie Santoni; Bruce Acres; Vincent Bataille; Marie-Pierre Chenard; Pascal Bleuzen; Jean-Marc Limacher; Reinhard Dummer
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

3.  Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042.

Authors:  Nathalie Accart; Mirjana Urosevic-Maiwald; Reinhard Dummer; Vincent Bataille; Nadine Kehrer; Cristina Niculescu; Jean-Marc Limacher; Marie-Pierre Chenard; Jean-Yves Bonnefoy; Ronald Rooke
Journal:  J Transl Med       Date:  2013-09-25       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.